Making the COVID-19 Oral Treatment: How 2,000+ Pfizer Team Members Made It Happen
As the potential threat of COVID-19 became clear by early 2020, teams across Pfizer sprang into action. Together, they worked to better understand the novel virus.
of cells, with the ability to trigger cell death. Because mitochondria that cause nerve cells to die, triggering the symptoms of Parkinson’s. …
Behind the Science Features
Press Releases
11.04.2013
10.03.2013
01.25.2013
01.03.2013
05.01.2012
12.30.2011
08.29.2011
06.19.2011
05.20.2011
08.09.2010
07.22.2010
02.24.2010
Media Resources
This information is intended for media professionals. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.
Clinical Trials
Our Careers